Across TCGA pan-cancer cohorts, BRINP3 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated BRINP3 data layer compared with 8 for mutation status and 1 for mass-spec protein.
The strongest signal is observed in kidney chromophobe (KICH), where higher BRINP3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BRINP3 expression acts as an unfavorable survival marker, although some lineages such as LUAD and LGG show a favorable association.
KICH, ACC, and LIHC are the cancer types where BRINP3 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.